Journal profile · ONCOLOGY-SURGERY
World Journal of Surgical Oncology
ISSN 1477-7819 · BioMed Central · ENGLAND · Irregular · Founded 2003
World Journal of Surgical Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.78; fully open access; APC about USD 3,090; median 102 days to acceptance (123 articles, last 24 months); community-reported acceptance: about 75%; 520 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
World Journal of Surgical Oncology is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Colorectal Cancer Surgical Treatments and Hepatocellular Carcinoma Treatment and Prognosis, together about 21.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics. Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-SURGERY
Editor-in-chief Manoj PandeyPublisher website
Editorial board by country: 3 in mainland China (about 7%); most named Italy 10, United States 6, Japan 5, Mainland China 3, United Kingdom 3 (46 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine7.3%
- Colorectal Cancer Surgical TreatmentsMedicine7.2%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine6.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6%
- Sarcoma Diagnosis and TreatmentMedicine5.7%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine5.4%
- Esophageal Cancer Research and TreatmentMedicine5.3%
- Gastrointestinal Tumor Research and TreatmentMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.78LetPub ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 1.03LetPub ·
- h-index
- 48LetPub ·
- h-index
- 101OpenAlex ·
- i10-index
- 3,452OpenAlex ·
- 2-year mean citedness
- 2.66OpenAlex ·
- Self-citation rate
- 3.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 507LetPub ·
- Downloads per year (publisher) 2025
- 3,700,000Publisher website ·
Articles by year OpenAlex count · 6,051 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 408 | 408 | 88 |
| 2025 | 520 | 520 | 1,190 |
| 2024 | 354 | 354 | 2,128 |
| 2023 | 393 | 393 | 3,328 |
| 2022 | 409 | 409 | 5,064 |
| 2021 | 350 | 350 | 6,730 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
102 daysMedian, submission to acceptance · P25–P75 67 days – 139 days
- Acceptance to online
- median 11 days (123 articles)
- Submission to online
- median 119 days
- Sample
- 123 articles with submission and acceptance dates (1,013 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,590 / USD 3,090 / GBP 2,290 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,990 / EUR 2,490 / GBP 2,190 | — | — | |
| LetPub | GBP 2,190 / USD 2,990 / EUR 2,490 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteExcerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Irregular
- Founded
- 2003
- ISSN
- 1477-7819
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about World Journal of Surgical Oncology
What CAS zone is World Journal of Surgical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, World Journal of Surgical Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of World Journal of Surgical Oncology?
The latest impact factor listed by LetPub is 2.78; CiteScore 4.3, h-index 101.
How long does peer review take at World Journal of Surgical Oncology?
Based on the dates recorded on 123 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 67–139 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of World Journal of Surgical Oncology based?
Of the 46 board members whose country the journal's board page names, 3 (about 7%) are in mainland China; the countries named most often are Italy (10), United States (6) and Japan (5). Counted from the institutions listed on the board page; for reference only.
Which databases index World Journal of Surgical Oncology?
According to LetPub and DOAJ records, World Journal of Surgical Oncology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is World Journal of Surgical Oncology open access, and what is the APC?
World Journal of Surgical Oncology is a fully open-access journal. APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .